hsa-mir-4761-5p _LIHC.png
hsa-mir-548ai _LIHC.png
hsa-mir-3202 _LIHC.png
MRO _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018826
Fusion event
HBV-MRO integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1717
Integrated sequence
CACCGTGAACGCCCACCAAATATTGCCCAAGGTCTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGAC| |TGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCAT
Host Sequence
Chromosome
chr18
Cytoband
q21.2
Reference genome
End
48325599/50799229 (Hg38)
Location type
Exon1
Target gene
miRNAs that regulate target gene
hsa-mir-2110 ; hsa-mir-491-5p ; hsa-mir-6780b-5p ; hsa-mir-4725-3p ; hsa-mir-4271 ; hsa-mir-5196-5p ; hsa-mir-4747-5p ; hsa-mir-3202 ; hsa-mir-3179 ; hsa-mir-203a-3p ; hsa-mir-6783-5p ; hsa-mir-3611 ; hsa-mir-3140-3p ; hsa-mir-7706 ; hsa-mir-4325 ; hsa-mir-7703 ; hsa-mir-616-3p ; hsa-mir-4537 ; hsa-mir-187-3p ; hsa-mir-4317 ; hsa-mir-6774-3p ; hsa-mir-92b-3p ; hsa-mir-92a-3p ; hsa-mir-367-3p ; hsa-mir-363-3p ; hsa-mir-32-5p ; hsa-mir-25-3p ; hsa-mir-6513-5p ; hsa-mir-887-5p ; hsa-mir-3913-5p ; hsa-mir-3122 ; hsa-mir-450a-1-3p ; hsa-mir-6780a-5p ; hsa-mir-6779-5p ; hsa-mir-3689c ; hsa-mir-3689b-3p ; hsa-mir-3689a-3p ; hsa-mir-30b-3p ; hsa-mir-1273h-5p ; hsa-mir-6788-5p ; hsa-mir-30c-2-3p ; hsa-mir-30c-1-3p ; hsa-mir-7977 ; hsa-mir-8085 ; hsa-mir-6731-5p ; hsa-mir-6878-5p ; hsa-mir-24-3p ; hsa-mir-4284 ; hsa-mir-4786-5p ; hsa-mir-383-3p ; hsa-mir-4761-5p ; hsa-mir-6516-5p ; hsa-mir-455-3p ; hsa-mir-6499-3p ; hsa-mir-6086 ; hsa-mir-377-5p ; hsa-mir-548s ; hsa-mir-6864-3p ; hsa-mir-3672 ; hsa-mir-4684-5p ; hsa-mir-3926 ; hsa-mir-769-5p ; hsa-mir-3190-5p ; hsa-mir-6827-3p ; hsa-mir-340-3p ; hsa-mir-6849-3p ; hsa-mir-6771-3p ; hsa-mir-548x-3p ; hsa-mir-548j-3p ; hsa-mir-548aq-3p ; hsa-mir-548am-3p ; hsa-mir-548aj-3p ; hsa-mir-548ah-3p ; hsa-mir-548ae-3p ; hsa-mir-548z ; hsa-mir-548h-3p ; hsa-mir-548d-3p ; hsa-mir-548bb-3p ; hsa-mir-548ac ; hsa-mir-210-5p ; hsa-mir-4749-3p ; hsa-mir-2276-3p ; hsa-mir-1248 ; hsa-mir-6810-3p ; hsa-mir-6801-3p ; hsa-mir-30e-5p ; hsa-mir-30d-5p ; hsa-mir-30c-5p ; hsa-mir-30b-5p ; hsa-mir-30a-5p ; hsa-mir-4693-3p ; hsa-mir-4461 ; hsa-mir-4279 ; hsa-mir-630 ; hsa-mir-570-5p ; hsa-mir-548ba ; hsa-mir-548ai ; hsa-mir-548ag ; hsa-mir-7109-3p ; hsa-mir-1273e ; hsa-mir-3689d ; hsa-mir-4459 ; hsa-mir-6134 ; hsa-mir-665 ; hsa-mir-6840-3p ; hsa-mir-6851-5p ; hsa-mir-6880-5p ; hsa-mir-7847-3p ; hsa-mir-3157-5p ; hsa-mir-4691-3p ; hsa-mir-6787-3p
Nearest miRNA
hsa-mir-1-2/Upstream/672666; hsa-mir-122/Downstream/2437872;
Upstream sequence
TGCTTGGGTGGATCTGTATGTGTGCATAAGTGTACATCTATGAGCTAAATTTTCACAGCCATTTGCCAAGATTAAGGAACAAAATAGGTGTCTAAAGATA
Downstream sequence
AATCCCAAGAGGCAAGCAGTGAGAAGAGGCATCCAGTGAGATAAAACAGGGGAACATGATGGCTCAGCAATGCACTCATACAGAACCATTTCCCTGCTGC
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate